| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0169-409X(97)00049-5 |
| P8608 | Fatcat ID | release_sqa6nkdp5fb7rpgn6r7w7qtz54 |
| P698 | PubMed publication ID | 10837563 |
| P2093 | author name string | McGinity JW | |
| O'Donnell PB | |||
| P2860 | cites work | Polylactic acid microspheres containing quinidine base and quinidine sulphate prepared by the solvent evaporation method. III. Morphology of the microspheres during dissolution studies | Q36441760 |
| Biodegradable poly(lactic acid) and poly(lactide-co-glycolide) microcapsules: problems associated with preparative techniques and release properties | Q37947040 | ||
| New methods of drug delivery | Q37970107 | ||
| Properties of multiphase microspheres of poly(dl-lactic acid) or poly(dl-lactic-co-glycolic acid) produced by mechanical agitation, sonication, or potentiometric dispersion | Q38560516 | ||
| Instability of bovine insulin in poly(lactide-co-glycolide) (PLGA) microspheres | Q38564318 | ||
| Biodegradable microspheres of poly(DL-lactic acid) containing piroxicam as a model drug for controlled release via the parenteral route | Q38567696 | ||
| Preparation and Characterization of 5-Fluorouracil-loaded Microparticles as Biodegradable Anticancer Drug Carriers | Q38574585 | ||
| Clinical evaluation of injectable biodegradable contraceptive system. | Q38579219 | ||
| Porous biodegradable microspheres for controlled drug delivery. I. Assessment of processing conditions and solvent removal techniques | Q38595141 | ||
| Microencapsulation and dissolution properties of a neuroleptic in a biodegradable polymer, poly(d,l-lactide). | Q38741182 | ||
| Polymers for the sustained release of proteins and other macromolecules | Q42102243 | ||
| In vivo and in vitro evaluation of a microencapsulated narcotic antagonist | Q45267267 | ||
| Microencapsulation using poly(DL-lactic acid). III: Effect of polymer molecular weight on the release kinetics | Q47444604 | ||
| Optimization of Preparative Conditions for Polylactide (PLA) Microspheres Containing Ovalbumin | Q54295391 | ||
| Long Acting Delivery Systems for Narcotic Antagonists II: Release Rates of Naltrexone from Poly(lactic Acid) Composites | Q66924054 | ||
| Chemical stability of insulin. 1. Hydrolytic degradation during storage of pharmaceutical preparations | Q67561985 | ||
| Simple gas chromatographic headspace analysis of residual organic solvent in microspheres | Q68071323 | ||
| Preparation of multi-phase microspheres of poly(D,L-lactic acid) and poly(D,L-lactic-co-glycolic acid) containing a W/O emulsion by a multiple emulsion solvent evaporation technique | Q68136251 | ||
| Polylactic acid microspheres containing quinidine base and quinidine sulphate prepared by the solvent evaporation technique. II. Some process parameters influencing the preparation and properties of microspheres | Q68843906 | ||
| Mechanism of hydrolytic degradation of poly(L-lactide) microcapsules: effects of pH, ionic strength and buffer concentration | Q68852916 | ||
| The preparation and evaluation of drug-containing poly(dl-lactide) microspheres formed by the solvent evaporation method | Q68853624 | ||
| Effects of plasma proteins on degradation properties of poly(L-lactide) microcapsules | Q69066929 | ||
| The formation and characterization of hydrocortisone-loaded poly((+/-)-lactide) microspheres | Q69882027 | ||
| Controlled delivery systems for proteins based on poly(lactic/glycolic acid) microspheres | Q70216445 | ||
| The preparation and characterization of poly(lactide-co-glycolide) microparticles. II. The entrapment of a model protein using a (water-in-oil)-in-water emulsion solvent evaporation technique | Q70639722 | ||
| Controlled delivery systems for proteins using polyanhydride microspheres | Q70684838 | ||
| Properties of multiphase microspheres of poly(D,L-lactic-co-glycolic acid) prepared by a potentiometric dispersion technique | Q71943416 | ||
| Entrapment of proteins in poly(L-lactide) microspheres using reversed micelle solvent evaporation | Q72380207 | ||
| Poly(lactide-co-glycolide) microcapsules for controlled release of steroids | Q93620502 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | microsphere | Q1759020 |
| P1104 | number of pages | 18 | |
| P304 | page(s) | 25-42 | |
| P577 | publication date | 1997-10-01 | |
| P1433 | published in | Advanced Drug Delivery Reviews | Q2825362 |
| P1476 | title | Preparation of microspheres by the solvent evaporation technique | |
| P478 | volume | 28 |
| Q50526635 | A novel technique for chitosan microparticle preparation using a water/silicone emulsion: green tea model. |
| Q40027648 | A short term quality control tool for biodegradable microspheres. |
| Q33351322 | Acidic microclimate pH distribution in PLGA microspheres monitored by confocal laser scanning microscopy |
| Q36589333 | Advanced materials and processing for drug delivery: the past and the future |
| Q46045226 | Alendronate PLGA microspheres with high loading efficiency for dental applications |
| Q43597578 | An investigation into the effects of residual water on the glass transition temperature of polylactide microspheres using modulated temperature DSC. |
| Q38448892 | Application of microencapsulated essential oils in cosmetic and personal healthcare products - a review. |
| Q43983904 | Biocompatible stabilizers in the preparation of PLGA nanoparticles: a factorial design study |
| Q36734622 | Biodegradable PLGA-Based Drug Delivery Systems for Modulating Ocular Surface Disease under Experimental Murine Dry Eye |
| Q57347153 | Biodegradable microspheres with poly(N-isopropylacrylamide) Enriched surface: Thermo-responsibility, biodegradation and drug release |
| Q41576547 | Carbopol 934-Sodium Alginate-Gelatin Mucoadhesive Ondansetron Tablets for Buccal Delivery: Effect of pH Modifiers |
| Q77969450 | Characterization of biodegradable drug delivery vehicles with the adhesive properties of leukocytes |
| Q44090029 | Characterization of ciclosporin A loaded poly (D,L lactide-co-glycolide) microspheres using modulated temperature differential scanning calorimetry |
| Q39923576 | Control of drug loading efficiency and drug release behavior in preparation of hydrophilic-drug-containing monodisperse PLGA microspheres |
| Q39983846 | Controlled initial surge despite high drug fraction and high solubility |
| Q33668837 | Controlled production of polymer microspheres from microgel-stabilized high internal phase emulsions. |
| Q44049110 | Controlled release of beta-estradiol from PLAGA microparticles: the effect of organic phase solvent on encapsulation and release |
| Q44556811 | Controlled release of imatinib mesylate from PLGA microspheres inhibit craniopharyngioma mediated angiogenesis |
| Q82732466 | Designing drug-loaded multi-layered polymeric microparticles |
| Q33521681 | Development and characterization of polymeric microspheres for controlled release protein loaded drug delivery system |
| Q48185685 | Development and characterization of solid dispersion-microsphere controlled release system for poorly water-soluble drug |
| Q37017458 | Development of a novel bioerodible dexamethasone implant for uveitis and postoperative cataract inflammation |
| Q57376730 | Double emulsion template suspension polymerisation: towards the synthesis of polyelectrolyte core porous hydrophobic shell particles for environmental applications |
| Q42261248 | Droplet based microfluidic fabrication of designer microparticles for encapsulation applications |
| Q35087552 | Drug carrier nanoparticles that penetrate human chronic rhinosinusitis mucus |
| Q37764989 | Drug delivery to solid tumors by elastin-like polypeptides |
| Q90741955 | Dual drug-loaded biodegradable Janus particles for simultaneous co-delivery of hydrophobic and hydrophilic compounds |
| Q91484213 | Effect of Different Tensoactives on the Morphology and Release Kinetics of PLA-b-PEG Microcapsules Loaded With the Natural Anticancer Compound Perillyl Alcohol |
| Q41918248 | Effect of chloroquine on phagolysosomal fusion in cultured guinea pig alveolar macrophages: implications in drug delivery |
| Q47291303 | Effect of poly(lactide-co-glycolide) molecular weight on the release of dexamethasone sodium phosphate from microparticles |
| Q44412073 | Effect of surfactant on the characteristics of biodegradable microcapsules |
| Q51019372 | Effect of the dispersion of Eudragit S100 powder on the properties of cellulose acetate butyrate microspheres containing theophylline made by the emulsion-solvent evaporation method. |
| Q33219524 | Effects of formulation factors on encapsulation efficiency and release behaviour in vitro of huperzine A-PLGA microspheres |
| Q34038697 | Effects of formulation parameters on encapsulation efficiency and release behavior of thienorphine loaded PLGA microspheres |
| Q51767489 | Effects of releasing recombinant human growth and differentiation factor-5 from poly(lactic-co-glycolic acid) microspheres for repair of the rat degenerated intervertebral disc. |
| Q77404271 | Encapsulation and release of rhodium(II) citrate and its association complex with hydroxypropyl-beta-cyclodextrin from biodegradable polymer microspheres |
| Q47153834 | Encapsulation of Antifouling Organic Biocides in Poly(lactic acid) Nanoparticles |
| Q43962321 | Encapsulation of antigenic extracts of Salmonella enterica serovar. Abortusovis into polymeric systems and efficacy as vaccines in mice. |
| Q39387324 | Engineering poly(lactic-co-glycolic acid) (PLGA) micro- and nano-carriers for Controlled Delivery of 17β-Estradiol |
| Q46929704 | Enteric controlled-release pantoprazole-loaded microparticles prepared by using Eudragit S100 and poly(epsilon-caprolactone) blend |
| Q28829681 | Ethyl cellulose nanoparticles as a platform to decrease ulcerogenic potential of piroxicam: formulation and in vitro/in vivo evaluation |
| Q92813337 | Eudragit: A Novel Carrier for Controlled Drug Delivery in Supercritical Antisolvent Coprecipitation |
| Q44189842 | Evaluation of Chlorpheniramine Maleate microparticles in orally disintegrating film and orally disintegrating tablet for pediatrics |
| Q44541499 | Evaluation of PLGA microspheres as delivery system for antitumor agent-camptothecin |
| Q48005235 | Evaluation of biodegradable polyester-co-lactone microparticles for protein delivery |
| Q42066382 | Fabrication and Characterization of Electrospun PCL-MgO-Keratin-Based Composite Nanofibers for Biomedical Applications |
| Q92732897 | Fabrication of Polymeric Microparticles by Electrospray: The Impact of Experimental Parameters |
| Q51689198 | Fabrication of uniform-sized poly-ɛ-caprolactone microspheres and their applications in human embryonic stem cell culture. |
| Q64268319 | Formation and Investigation of Electrospun Eudragit E100/Oregano Mats |
| Q33290413 | Formation of acylated growth hormone-releasing peptide-6 by poly(lactide-co-glycolide) and its biological activity |
| Q92408503 | Formulation and Physicochemical Characterization of Cyclosporine Microfiber by Electrospinning |
| Q44569415 | Formulation and characterization of ethylcellulose microparticles containing .L-alanyl- L-glutamine peptide. |
| Q51684103 | Formulation and development of orodispersible sustained release tablet of domperidone. |
| Q39225535 | Formulation and evaluation of controlled release ethylcellulose and polyethylene glycol microspheres containing metoprolol tartrate. |
| Q51218663 | Formulation and in vitro evaluation of bisphosphonate loaded microspheres for implantation in osteolysis. |
| Q38027859 | Formulation strategies for sustained release of proteins |
| Q42700206 | Function of sustained released resveratrol on IL-1β-induced hBMSC MMP13 secretion inhibition and chondrogenic differentiation promotion. |
| Q51158186 | Heparin immobilized porous PLGA microspheres for angiogenic growth factor delivery. |
| Q37518860 | Highly loaded, sustained-release microparticles of curcumin for chemoprevention |
| Q45161838 | Hydrophobic ion pair formation between leuprolide and sodium oleate for sustained release from biodegradable polymeric microspheres |
| Q51132021 | Implantation of vancomycin microspheres in blend with human/rabbit bone grafts to infected bone defects. |
| Q38922491 | Improved Poly (D,L-lactide) nanoparticles-based formulation for hair follicle targeting |
| Q42422910 | In silico modelling of drug-polymer interactions for pharmaceutical formulations |
| Q51840991 | In situ pore formation in a polymer matrix by differential polymer degradation. |
| Q36958803 | In vitro and in vivo suppression of cellular activity by guanidinoethyl disulfide released from hydrogel microspheres composed of partially oxidized hyaluronan and gelatin |
| Q50518218 | In vitro release characteristics and cellular uptake of poly(D,L-lactic-co-glycolic acid) nanoparticles for topical delivery of antisense oligodeoxynucleotides. |
| Q43922579 | Influence of irradiation sterilization on poly(lactide-co-glycolide) microspheres containing anti-inflammatory drugs |
| Q36276099 | Influence of particle size and antacid on release and stability of plasmid DNA from uniform PLGA microspheres |
| Q47307465 | Influence of secondary preparative parameters and aging effects on PLGA particle size distribution: a sedimentation field flow fractionation investigation |
| Q41989234 | Investigations on the physical structure and the mechanism of drug release from an enteric matrix microspheres with a near-zero-order release kinetics using SEM and quantitative FTIR |
| Q52708095 | Ivermectin-loaded microparticles for parenteral sustained release: in vitro characterization and effect of some formulation variables. |
| Q55336770 | Magnesium incorporated chitosan based scaffolds for tissue engineering applications. |
| Q57381726 | Magnetic targeting for site-specific drug delivery: applications and clinical potential |
| Q37638223 | Magnetic-based multi-layer microparticles for endothelial progenitor cell isolation, enrichment, and detachment |
| Q42235449 | Mass transfer in the dissolution of a multicomponent liquid droplet in an immiscible liquid environment |
| Q58910693 | Micro- and Nano-Carrier Mediated Intra-Articular Drug Delivery Systems for the Treatment of Osteoarthritis |
| Q37176404 | Micro/nanostructured polymeric systems for biomedical and pharmaceutical applications |
| Q33514058 | Microencapsulation of cytarabine using poly(ethylene glycol)-poly(epsilon-caprolactone) diblock copolymers as surfactant agents |
| Q54763754 | Microencapsulation of mildronate in biodegradable and non-biodegradable polymers. |
| Q50971339 | Microparticle delivery of Interleukin-7 to boost T-cell proliferation and survival. |
| Q35721717 | Microparticle-based delivery of oxytocin receptor antisense DNA in the medial amygdala blocks social recognition in female mice |
| Q82301907 | Microsphere preparation using the untoxic solvent glycofurol |
| Q35609775 | Microspheres for controlled release drug delivery |
| Q63989186 | Microspheres for protein delivery prepared from amphiphilic multiblock copolymers |
| Q49902777 | Modified two-step emulsion solvent evaporation technique for fabricating biodegradable rod-shaped particles in the submicron size range |
| Q44980682 | Modulation of HIV peptide antigen specific cellular immune response by synthetic α- and β-defensin peptides |
| Q38889924 | Multi-layered polymeric nanoparticles for pH-responsive and sequenced release of theranostic agents. |
| Q51123426 | Multifunctional conjugation of proteins on/into bio-nanoparticles prepared by amphiphilic poly(gamma-glutamic acid). |
| Q38009567 | Nanofiber-based delivery of bioactive agents and stem cells to bone sites. |
| Q50999753 | Nasal delivery of PLG microparticle encapsulated defensin peptides adjuvanted gp41 antigen confers strong and long-lasting immunoprotective response against HIV-1. |
| Q47173216 | Nasal delivery of high molecular weight drugs. |
| Q36782519 | Natural origin biodegradable systems in tissue engineering and regenerative medicine: present status and some moving trends |
| Q43112420 | One-step fabrication of triple-layered polymeric microparticles with layer localization of drugs as a novel drug-delivery system |
| Q51186643 | Optimization of the entrapment of bacterial cell envelope extracts into microparticles for vaccine delivery. |
| Q46743893 | Optimizing double emulsion process to decrease the burst release of protein from biodegradable polymer microspheres |
| Q58441734 | Optimizing the Process Parameters for Encapsulation of Linamarin into PLGA Nanoparticles Using Double Emulsion Solvent Evaporation Technique |
| Q59060859 | Organic Nanovesicular Cargoes for Sustained Drug Delivery: Synthesis, Vesicle Formation, Controlling “Pearling” States, and Terfenadine Loading/Release Studies |
| Q39176645 | Osmogen-Mediated One-Step Technique of Fabricating Hollow Microparticles for Encapsulation and Delivery of Bioactive Molecules |
| Q46041557 | PLGA and PHBV microsphere formulations and solid-state characterization: possible implications for local delivery of fusidic acid for the treatment and prevention of orthopaedic infections |
| Q51132030 | PLGA microspheres with high drug loading and high encapsulation efficiency prepared by a novel solvent evaporation technique. |
| Q38594961 | Particles from preformed polymers as carriers for drug delivery. |
| Q53654635 | Pharmacokinetic and pharmacodynamic evaluation of floating microspheres of metformin hydrochloride. |
| Q35931707 | Piperine containing floating microspheres: an approach for drug targeting to the upper gastrointestinal tract. |
| Q30872229 | Poly(D,L-lactide-co-glycolide) encapsulated poly(vinyl alcohol) hydrogel as a drug delivery system |
| Q50965287 | Poly(ethylene glycol)-poly(lactic-co-glycolic acid) core-shell microspheres with enhanced controllability of drug encapsulation and release rate. |
| Q39148835 | Poly(lactide-co-glycolide) nanoparticles, layer by layer engineered for the sustainable delivery of antiTNF-α. |
| Q50988058 | Preparation and characterization of 45S5 bioactive glass-based scaffolds loaded with PHBV microspheres with daidzein release function. |
| Q30993448 | Preparation and characterization of biomimetic adsorbent from poly-3-hydroxybutyrate |
| Q46806983 | Preparation and characterization of honokiol nanoparticles |
| Q33308354 | Preparation and characterization of quercetin-loaded polymethyl methacrylate microcapsules using a polyol-in-oil-in-polyol emulsion solvent evaporation method |
| Q39377206 | Preparation and evaluation of polymer based microcarriers for all-trans-retinoic acid |
| Q46601051 | Preparation and in vitro evaluation of propylthiouracil microspheres made of Eudragit RL 100 and cellulose acetate butyrate polymers using the emulsion-solvent evaporation method |
| Q53072964 | Preparation and in vitro/in vivo evaluation of PLGA microspheres containing norquetiapine for long-acting injection. |
| Q39617984 | Preparation and in vitro characterization of vascular endothelial growth factor (VEGF)-loaded poly(D,L-lactic-co-glycolic acid) microspheres using a double emulsion/solvent evaporation technique |
| Q47746118 | Preparation of keratin-based microcapsules for encapsulation of hydrophilic molecules. |
| Q33219523 | Preparation, characterization and in vitro release properties of ibuprofen-loaded microspheres based on polylactide, poly(epsilon-caprolactone) and their copolymers |
| Q35728753 | Radiation-guided drug delivery systems |
| Q57794651 | Readily Functionalizable and Stabilizable Polymeric Particles with Controlled Size and Morphology by Electrospray |
| Q53492987 | Regenerative nano-hybrid coating tailored for autonomous corrosion protection. |
| Q91962622 | Risperidone-Loaded PLGA-Lipid Particles with Improved Release Kinetics: Manufacturing and Detailed Characterization by Electron Microscopy and Nano-CT |
| Q42823446 | Selective Retardation of Perfume Oil Evaporation from Oil-in-Water Emulsions Stabilized by Either Surfactant or Nanoparticles |
| Q35960408 | Simultaneous Determination of Glass Transition Temperatures of Several Polymers |
| Q30855198 | Smart Microparticles with a pH-responsive Macropore for Targeted Oral Drug Delivery |
| Q79719486 | Stereological analysis of the poly-(DL-lactide-co-glycolide) submicron sphere prepared by solvent/non-solvent chemical methods and centrifugal processing |
| Q44740631 | Study of intracellular delivery of doxorubicin from poly(lactide-co-glycolide) nanoparticles by means of fluorescence lifetime imaging and confocal Raman microscopy. |
| Q33837244 | Surface functionalization of polyketal microparticles with nitrilotriacetic acid-nickel complexes for efficient protein capture and delivery. |
| Q43717805 | Sustained release of etanidazole from spray dried microspheres prepared by non-halogenated solvents |
| Q53246028 | Synthesis of temperature-responsive dextran-MA/PNIPAAm particles for controlled drug delivery using superhydrophobic surfaces. |
| Q43698644 | Targeting drug delivery to radiation-induced neoantigens in tumor microvasculature |
| Q35185327 | Taste masked microspheres of ofloxacin: formulation and evaluation of orodispersible tablets |
| Q38169084 | The application of microencapsulation techniques in the treatment of endodontic and periodontal diseases |
| Q37361007 | The solution and solid state stability and excipient compatibility of parthenolide in feverfew |
| Q46540548 | The use of response surface methodology in the evaluation of captopril microparticles manufactured using an oil in oil solvent evaporation technique |
| Q46287948 | Towards more realistic in vitro release measurement techniques for biodegradable microparticles |
| Q37109219 | Using poly(lactic-co-glycolic acid) microspheres to encapsulate plasmid of bone morphogenetic protein 2/polyethylenimine nanoparticles to promote bone formation in vitro and in vivo |
| Q36712817 | Vaccine delivery using nanoparticles. |
Search more.